RUBINSTEIN JULIE (President) sold 4.8% of their position (19.04K shares) of ADAPTIVE BIOTECHNOLOGIES CORP on the open market
Open‑market sale worth $270.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/29/2026ACC: 0001780664-26-000032
Officer· President
Since Jun 2019
-19.04K
Net shares
Net seller
$270.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
14.71K acquired · 33.74K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+14.71K
Price / share
$8.46
Trade value
$124.42K
% of position
3.8%
4/27/2026
382.13K→396.84K
Common Stock
Direct
Shares
−19.04K
Price / share
$14.23
Trade value
$270.90K
% of position
4.8%
4/27/2026
396.84K→377.80K
Total
Net shares
−4.33K
Net value
-$146.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/27/2026 | M · Option Exercise | +14.71K | $8.46 | $124.42K | 3.8% | 382.13K | 396.84K |
| Common Stock Direct | 4/27/2026 | S · Sale | −19.04K | $14.23 | $270.90K | 4.8% | 396.84K | 377.80K |
| Total | −4.33K | -$146.48K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
14.71K shares
Shares
−14.71K
Strike price
8.46
Held after
45.73K
Exercisable
—
4/27/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock14.71K shares | 4/27/2026 | M · Option Exercise | −14.71K | 8.46 | — | 45.73K |